Similar medications and substitutes for MOGAMULIZUMAB-KPKC
In short: Poteligeo (MOGAMULIZUMAB-KPKC) belongs to the Chemokine Receptor Type 4 Interaction class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Poteligeo is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Poteligeo in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.